Finance entity
markets is the sole category represented across all 1 tracked stories. Briumvi is most often covered alongside TG Therapeutics, Inc., which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.5 for the broader beat in this window.
Last mentioned: Mar 10, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
markets is the sole category represented across all 1 tracked stories. Briumvi is most often covered alongside TG Therapeutics, Inc., which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.5 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 6.3 in the same window. Briumvi appears in 1 tracked Finance story from March 10, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 88 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Briumvi. Shared-story counts are live from our verified record — not editorial picks.
Winton Group Ltd has acquired 113,951 shares of TG Therapeutics, signaling institutional confidence in the biotech firm's commercial execution. The move follows recent financial disclosures and suggests a data-driven endorsement of the company's growth trajectory in the multiple sclerosis market.
Briumvi is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
